Effects of KHEYLRFamide and KNEFIRFamide on cyclic adenosine monophosphate levels in Ascaris suum somatic muscle

International Journal for Parasitology

Volumn 33, Issue 2, 2003, Pages 199-208

  Thompson, D P ^a   Davis, J P ^a   Larsen, M J ^a   Coscarelli, E M ^a   Zinser, E W ^a   Bowman, J W ^a   Alexander Bowman, S J ^a   Marks, N J ^b   Geary, T G ^a  

^a PFIZER INC   (United States)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Ascaris suum; Cyclic adenosine monophosphate; FMRFamide related peptides; Second messenger

Indexed keywords

ALANYLHISTIDYLGLUTAMYLTYROSYLLEUCYLARGINYLPHENYLALANINAMIDE; CYCLIC AMP; CYCLIC GMP; CYCLO(DEXTRO LACTYL N METHYLLEUCYL DEXTRO 3 PHENYLLACTYL N METHYLLEUCYL DEXTRO LACTYL N METHYLLEUCYL DEXTRO 3 PHENYLLACTYL N METHYLLEUCYL); CYCLODEPSIPEPTIDE; INOSITOL 1,4,5 TRISPHOSPHATE; LYSYLALANYLGLUTAMYLTYROSYLLEUCYLARGINYLPHENYLALANINAMIDE; LYSYLASPARAGINYLGLUTAMYLPHENYLALANYLISOLEUCYLALANYLPHENYLALANINAMIDE; LYSYLASPARAGINYLGLUTAMYLPHENYLALANYLISOLEUCYLARGINYLPHENYLALANINAMIDE; LYSYLASPARAGINYLGLUTAMYLPHENYLALANYLLEUCYLARGINYLPHENYLALANINAMIDE; LYSYLASPARAGINYLPHENYLALANYLISOLEUCYLALANYLPHENYLALANINAMIDE; LYSYLHISTIDYLALANYLTYROSYLLEUCYLARGINYLPHENYLALANINAMIDE; LYSYLHISTIDYLGLUTAMYLALANYLLEUCYLARGINYLPHENYLALANINAMIDE; LYSYLHISTIDYLGLUTAMYLTYROSYLALANYLARGINYLPHENYLALANINAMIDE; LYSYLHISTIDYLGLUTAMYLTYROSYLLEUCYLALANYLPHENYLALANINAMIDE; LYSYLHISTIDYLGLUTAMYLTYROSYLLEUCYLARGINYLALANINAMIDE; LYSYLHISTIDYLGLUTAMYLTYROSYLLEUCYLARGINYLPHENYLALANINAMIDE; LYSYLHISTIDYLGLUTAMYLTYROSYLLEUCYLARGINYLPHENYLALANINE HYDROXIDE; NEUROPEPTIDE; PEPTIDE; SERYLASPARTYLPROLYLASPARAGINYLPHENYLALANYLLEUCYLARGINYLPHENYLALANINAMIDE; UNCLASSIFIED DRUG;

PARASITOLOGY;

ANIMAL TISSUE; ARTICLE; ASCARIS SUUM; BLOOD LEVEL; CHRONOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENERVATION; DORSAL ROOT; DRUG EFFECT; DRUG POTENCY; FEMALE; MEASUREMENT; MUSCLE; MUSCLE EXCITATION; MUSCLE TONE; NEMATODE; NONHUMAN; PROTEIN FUNCTION; RECORDING; STIMULATION; VENTRAL ROOT;

ASCARIS SUUM; NEMATODA;

EID: 0037291205     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(02)00259-X     Document Type: Article

References (44)

1. Bowman J.W., Winterrowd C.A., Friedman A.R., Thompson D.P., Klein R.D., Davis J.P., Maule A.G., Blair K.L., Geary T.G. Nitric oxide mediates the inhibitory effects of SDPNFLRFamide, a nematode FMRFamide-related neuropeptide, in Ascaris suum. J. Neurophysiol. 74:1995;1880-1888.
2. Bowman J.W., Friedman A.R., Thompson D.P., Ichhpurani A.K., Kellman M.F., Marks N., Maule A.G., Geary T.G. Structure-activity relationships of KNEFIRFamide (AF1), a nematode FMRFamide-related peptide, on Ascaris suum muscle. Peptides. 17:1996;381-387.
3. Brownlee D.J.A., Holden-Dye L., Walker R.J. The action of serotonin and the nematode neuropeptide KSAYMRFamide on the pharyngeal muscle of the parasitic nematode Ascaris suum. Parasitology. 111:1995;379-384.
4. Brownlee D.J.A., Fairweather I., Holden-Dye L., Walker R.J. Nematode neuropeptides: localization, isolation and functions. Parasitol. Today. 12:1996;343-351.
5. Burns T.W., Terr B.E., Langley P.E., Robison G.A. Role of cyclic AMP in human adipose tissue lipolysis. Hamert P., Sands H. Advances in Cyclic Nucleotide Research. 1980;329-339 Raven, New York.
6. Cho-Chung Y.S. On the mechanism of cyclic CMP-mediated growth arrest of solid tumors. Hamert P., Sands H. Advances in Cyclic Nucleotide Research. 1980;329-339 Raven, New York.
7. Conder G.A., Johnson S.S., Nowakowski D.S., Blake T.E., Dutton F.E., Nelson S.J., Thomas E.M., Davis J.P., Thompson D.P. Anthelmintic profile of the cyclodepsipeptide PF1022A in in vitro and in vivo models. J. Antibiot. 48:1995;820-823.
8. Cowden C., Stretton A.O.W. AF2, an Ascaris neuropeptide: Isolation, sequence and bioactivity. Peptides. 14:1993;423-430.
9. Cowden C., Stretton A.O.W., Davis R. AF1, a sequenced, bioactive neuropeptide isolated from the nematode Ascaris suum. Neuron. 2:1989;1465-1473.
10. Cunningham B.C., Wells J.A. High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science. 244:1989;1081-1085.
11. Donahue M.J., Yacoub N.J., Michnoff C.A., Masaracchia R.M., Harris B.G. Serotonin (5-hydroxytryptamine): A possible regulator of glycogenolysis in perfused muscle segments of Ascaris suum. Biochem. Biophys. Res. Commun. 101:1981;112-117.
12. Donahue M.J., Yacoub H., Harris B. Correlation of muscle activity with glycogen metabolism in muscle of Ascaris suum. Am. J. Physiol. 242:1982;R514-R521.
13. Dutton F.E., Nelson S.J. Synthesis of PF1022A, an anthelmintic cyclodepsipeptide. J. Antibiot. 47:1994;1322-1327.
14. Fellowes R.A., Maule A.G., Marks N.J., Geary T.G., Thompson D.P., Shaw C., Halton D.W. Modulation of the motility of the vagina vera of Ascaris suum in vitro by FMRFamide-related peptides. Parasitol. 116:1998;277-287.
15. Fellowes R.A., Maule A.G., Marks N.J., Geary T.G., Thompson D.P., Halton D.W. Neuropeptide modulation of the vagina vera of Ascaris suum: in vitro effects of PF1, PF2, PF4, AF3 and AF4. Parasitology. 120:2000;79-89.
16. Geary T.G., Marks N.J., Maule A.G., Bowman J.W., Alexander-Bowman S.J., Larsen M.L., Kubiak T.M., Davis J.P., Thompson D.P. Pharmacology of FMRFamide-related peptides (FaRPs) in helminths. Ann. N.Y. Acad. Sci. 897:1999;212-227.
17. Keating C.D., Holden-Dye L., Walker R.J. Investigation of the mode of action of nematode neuropeptides. Pest. Sci. 46:1996;263-266.
18. Krause E., Wollenberger A. Cyclic nucleotides in heart and acute myocardial ischemia and hypoxia. Hamert P., Sands H. Advances in Cyclic Nucleotide Research. 1980;49-58 Raven, New York.
19. Kubiak T.M., Maule A.G., Marks N.J., Martin R.A., Wiest J.R. Importance of the proline residue to the functional activity and metabolic stability of the nematode FMRFamide-related peptide, KPNFIRFamide (PF4). Peptides. 17:1996;1267-1277.
20. Lee B.H., Dutton F.E., Clothier M.F., Thomas E.W., Bowman J.W., Davis J.P., Johnson S.S., Zantello M.R., Zinser E.W., McGuire J.C., Thompson D.P., Geary T.G. Synthesis and biological activity of anthelmintic thiadiazoles using an AF-2 receptor binding assay. Bioorg. Med. Chem. Lett. 9:1999;1727-1732.
21. Marks N.J., Shaw C., Davis J.P., Maule A.G., Halton D.W., Verheart P., Geary T.G., Thompson D.P. Isolation of AF2 (KHEYLRFamide) from Caenorhabditis elegans: evidence for the presence of more than one FMRFamide-related peptide-encoding gene. Biochem. Biophys. Res. Commun. 217:1995;845-851.
22. Marks N.J., Johnson S., Maule A.G., Halton D.W., Shaw C., Geary T.G., Moore S., Thompson D.P. Physiological effects of platyhelminth RFamide peptides on muscle-strip preparations of Fasciola hepatica (Trematoda: Digenea). Parasitology. 113:1996;393-401.
23. Marks N.J., Maule A.G., Halton D.W., Geary T.G., Shaw C., Thompson D.P. Pharmacological effects of nematode FMRFamide-related peptides (FaRPs) on muscle contractility of the trematode, Fasciola hepatica. Parasitology. 114:1997;531-539.
24. Marks N.J., Sangster N.C., Maule A.G., Halton D.W., Thompson D.P., Geary T.G., Shaw C. Structural characterisation and pharmacology of KHEYLRFamide (AF2) and KSAYMRFamide (PF3/AF8) from Haemonchus contortus. Mol. Biochem. Parasitol. 100:1999;185-194.
25. Martin R.J., Pennington R.J., Duittoz A.H., Robertson S., Kusel J.R. The physiology and pharmacology of neuromuscular transmission in the nematode parasite, Ascaris suum. Parasitology. 111:1991;379-384.
26. Martin R.J., Harder A., Londershausen M., Jeschke P. Anthelmintic actions of the cyclic depsipeptide PF1022a and its electrophysiological effects on muscle cells of Ascaris suum. Pest. Sci. 48:1996;343-349.
27. Maule A.G., Shaw C., Bowman J.W., Halton D.W., Thompson D.P., Geary T.G., Thim L. The FMRFamide-like neuropeptide AF2 (Ascaris suum) is present in the free-living nematode, Paragrellus redivivus (Nematoda, Rhabditida). Parasitology. 109:1994;351-356.
28. Maule A.G., Geary T.G., Bowman J.W., Marks N.J., Blair K.L., Halton D.W., Shaw C., Thompson D.P. Ascaris suum: comparative studies on the effects of nematode FMRFamide-related peptides (FaRPs) on muscle strip preparations. Invert. Neurosci. 1:1995;255-265.
29. Maule A.G., Geary T.G., Bowman J.W., Shaw C., Halton D.W., Shaw C., Thompson D.P. The pharmacology of nematode FMRFamide-related peptides. Parasitol. Today. 12:1996;351-357.
30. Maule A.G., Day T.A. Parasitic peptides! The structure and function of neuropeptides in parasitic worms. Peptides. 20:1999;999-1019.
31. Pang F.-Y., Mason J., Holden-Dye L., Franks C.J., Williams R.G., Walker M.J. The effects of the nematode peptide, KHEYLRFamide (AF2), on the somatic musculature of the parasitic nematode, Ascaris suum. Parasitology. 110:1995;353-362.
32. Reich G., Doble K.E., Price D.A., Greenberg M.J. Effects of cardioactive peptides on myocaridal cAMP levels in the snail Helix aspersa. Peptides. 18:1997;355-360.
33. Reinitz C.A., Stretton A.O.W. Behavioral and cellular effects of serotonin on locomotion and male mating posture in Ascaris suum. J. Comp. Physiol. 178:1996;655-667.
34. Reinitz C.A., Herfel H.G., Messinger L.A., Stretton A.O.W. Changes in locomotory behavior and cAMP produced in Ascaris suum by neuropeptides from Ascaris and C. elegans. Mol. Biochem. Parasitol. 111:2000;185-197.
35. Rogers C.M., Franks C.J., Walker R.J., Burke J.F., Holden-Dye L. Regulation of the pharynx of Caenorhabditis elegans by 5-HT, octopamine, and FMRFamide-like neuropeptides. J. Neurobiol. 49:2001;235-244.
36. 2) by the nematode, Ascaris suum. Abstr. Biochem. Soc. Trans. 22:1994;293S.
37. Sajiid M., Isaac R.E. Identification and properties of a neuropeptide-degrading endopeptidase (neprilysin) of Ascaris suum muscle. Parasitology. 111:1995;599-608.
38. Saz H.J. Energy metabolisms of parasitic helminths: adaptations to parasitism. Annu. Rev. Physiol. 43:1981;323-341.
39. Sheehy B., Ho N.F.H., Burton P.S., Day J.S., Geary T.G., Thompson D.P. Transport of model peptides across Ascaris suum cuticle. Mol. Biochem. Parasitol. 105:2000;39-49.
40. Sims S.M., Ho N.F.H., Magas L.T., Geary T.G., Barsuhn C.L., Thompson D.P. Biophysical model of the transcuticular excretion of organic acids, cuticle pH and buffer capacity in gastrointestinal nematodes. J. Drug Target. 2:1994;1-8.
41. Thomas M.K., Francis S.H., Beebe S.J., Gettys T.W., Corbin J.D. Partial mapping of cyclic nucleotide sites and studies of regulatory mechanisms of phosphodiesterase using cyclic nucleotide analogs. Strada S.J., Hidaka H. Advances in Cyclic Nucleotide Research. 1992;45-53 Raven, New York.
42. Trim N., Brooman J.E., Holden-Dye L., Walker R.J. The role of cAMP in the actions of the peptide AF3 in the parasitic nematodes Ascaris suum and Ascaridia galli. Mol. Biochem. Parasitol. 93:1998;263-271.
43. Willett J.D. Control mechanisms in nematodes. Zuckeman B.M. Nematodes as Biological Models. 1980;197-225 Academic Press, New York.
44. N (nematode) receptor from Ascaris suum muscle. Comp. Biochem. Physiol. 101C. 1992;469-474.